Mediation effect of inflammatory biomarkers on the association between blood lead levels and blood pressure changes in Chinese adults.
10.3760/cma.j.cn112150-20211119-01067
- Author:
Ying Li QU
1
;
Feng ZHAO
1
;
Sai Sai JI
1
;
Xiao Jian HU
1
;
Zheng LI
1
;
Miao ZHANG
1
;
Ya Wei LI
1
;
Yi Fu LU
1
;
Jia Yi CAI
1
;
Qi SUN
1
;
Hao Can SONG
1
;
Dan Dan LI
1
;
Xu Lin ZHENG
1
;
Bing WU
1
;
Yao Bin LV
1
;
Ying ZHU
1
;
Zhao Jin CAO
1
;
Xiao Ming SHI
1
Author Information
1. China CDC Key Laboratory of Environment and Population Health/National Institute of Environmental Health, Chinese Center for Disease Control and Prevention, Beijing 100021, China.
- Publication Type:Journal Article
- MeSH:
Adult;
Male;
Humans;
Blood Pressure/physiology*;
C-Reactive Protein/analysis*;
Lead;
Arsenic/analysis*;
Cadmium;
Biomarkers;
Hypertension/epidemiology*;
China/epidemiology*
- From:
Chinese Journal of Preventive Medicine
2022;56(11):1591-1596
- CountryChina
- Language:Chinese
-
Abstract:
Objective: To investigate the role of inflammatory biomarkers in the relationship between blood lead levels and blood pressure changes. Methods: A total of 9 910 people aged 18-79 years who participated in the China National Human Biomonitoring in 2017-2018 were included in this study. A self-made questionnaire was used to collect demographic characteristics, lifestyle and other information, and the data including height, weight and blood pressure were determined through physical examination. Blood and urinary samples were collected for the detection of blood lead and cadmium levels, urinary arsenic levels, white blood cells, neutrophils, lymphocytes, and hypersensitive C-reactive protein (hs-CRP). Weighted linear regression models were used to evaluate the associations between blood lead, inflammatory biomarkers and blood pressure. Mediation analysis was performed to investigate the role of inflammation in the relationship between blood lead levels and blood pressure changes. Results: The median (Q1, Q3) age of all participants was 45.4 (33.8, 58.4)years, including 4 984 males accounting for 50.3%. Multivariate logistic regression model analysis showed that after adjusting for age, gender, residence area, BMI, education level, smoking and drinking status, family history of hypertension, consumption frequency of rice, vegetables, and red meat, fasting blood glucose, total cholesterol, triglycerides, blood cadmium and urinary arsenic levels, there was a positive association between blood lead levels, inflammatory biomarkers and blood pressure (P<0.05). Each 2.71 μg/L (log-transformed) increase of the lead was associated with a 2.05 (95%CI: 0.58, 3.53) mmHg elevation in systolic blood pressure (SBP), 2.24 (95%CI: 1.34, 3.14) mmHg elevation in diastolic blood pressure (DBP), 0.25 (95%CI: 0.05, 0.46) mg/L elevation in hs-CRP, 0.16 (95%CI: 0.03, 0.29)×109/L elevation in white blood cells, and 0.11 (95%CI: 0.02, 0.21)×109/L elevation in lymphocytes, respectively. Mediation analysis showed that the levels of hs-CRP significantly mediated the association of blood lead with SBP, with a proportion about 3.88% (95%CI: 0.45%, 7.32%). The analysis also found that the levels of hs-CRP and neutrophils significantly mediated the association of blood lead with SBP, with a proportion about 4.10% (95%CI: 1.11%, 7.10%) and 2.42% (95%CI: 0.07%, 4.76%), respectively. Conclusion: This study suggests that inflammatory biomarkers could significantly mediate the association of blood lead levels and blood pressure changes.
